Expertise in
1
conditions

Satoru Ishikawa

Tsukuba, JP 
Expertise in
1
conditions
Tsukuba, JP 

Overview

Satoru Ishikawa practices practicing medicine in Tsukuba, Japan.

Mr. Ishikawa is highly rated in 1 condition, according to our data. His clinical expertise encompasses Pyruvate Carboxylase Deficiency, Pulmonary Tuberculosis, COVID-19, and Methicillin-Resistant Staphylococcus Aureus (MRSA).

He is actively involved in clinical research, co-authoring 43 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Tsukuba, 3058604, Japan
Other Locations
Funabashi, 2738556, Japan
Chuo, 2608712, Japan
Chiba, 2608712, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Japanese Idiopathic Interstitial Pneumonias Registry
Japanese Idiopathic Interstitial Pneumonias Registry
Enrollment Status: Active_not_recruiting
Publish Date: February 05, 2026
A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
Enrollment Status: Completed
Publish Date: September 23, 2024
Intervention Type: Biological, Drug
Study Drugs: Otilimab, Standard of Care
Study Phase: Phase 2
View 1 Less Clinical Trial

43 Total Publications

Effects of environmental factors on arsenic accumulation in rice under field conditions using a Bayesian state space model.
Effects of environmental factors on arsenic accumulation in rice under field conditions using a Bayesian state space model.
Journal: Scientific reports
Published: November 10, 2025

Frequently Asked Questions about Satoru Ishikawa

Is Satoru Ishikawa a top-rated expert for Pyruvate Carboxylase Deficiency?

MediFind is an objective health platform that identifies experts based on real-world data. Satoru Ishikawa is classified as an Advanced expert for Pyruvate Carboxylase Deficiency, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Satoru Ishikawa participate in research or clinical trials?

Yes. Satoru Ishikawa has published 43 articles and abstracts on conditions like Pyruvate Carboxylase Deficiency. You can view a list of Satoru Ishikawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ishikawa's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile